Drug profile · INN
gadoxetate disodium
EOVIST
gadoxetate disodium (EOVIST) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — gadoxetate disodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
gadoxetate disodium (EOVIST) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN gadoxetate disodium
Brand EOVIST
Mechanism Unknown
Route INTRAVENOUS
Formulation SOLUTION
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is gadoxetate disodium?
gadoxetate disodium (EOVIST) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for gadoxetate disodium?
EOVIST is a marketed brand name for gadoxetate disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gadoxetate disodium?
gadoxetate disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.